AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Food Science Article
PDF (10 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Mechanistic Study of Lycium ruthenicum Polysaccharides in Ameliorating Diabetes Complicated by Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice Based on the Gut-Liver Axis

Yao ZHAO1 Ming QIAO1Junping HU2,3Jianhua YANG1,4 ( )
Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi 830054, China
College of Pharmacy, Xinjiang Medical University, Ürümqi 830017, China
Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Ürümqi 830017, China
Xinjiang Key Laboratory of Clinical Drug Research, Ürümqi 830054, China
Show Author Information

Abstract

This study aimed to investigate the ameliorative effects of Lycium ruthenicum polysaccharides (LRP) on type 2 diabetes mellitus (T2DM) complicated by metabolic dysfunction-associated steatotic liver disease (MASLD) and to elucidate its underlying mechanisms. db/db mice were randomly divided into six groups: control, model, low-, medium-, and high-dose LRP (50, 100, and 200 mg/kg), and simvastatin (10 mg/kg). The intervention period lasted for eight weeks. Metagenomic sequencing and gas chromatography-mass spectrometry (GC-MS) were used to evaluate the effect of LRP on serum biochemical parameters, hepatic histopathology, gut microbiota structure, and short-chain fatty acid (SCFA) profiles in mice. LRP treatment significantly reduced serum alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, low-density lipoprotein cholesterol, free fatty acids, lipopolysaccharide, and pro-inflammatory cytokine levels, while alleviating hepatic lipid accumulation, inflammation, and fibrosis. Moreover, LRP enhanced the α-diversity of the gut microbiota, increased the relative abundance of beneficial bacteria such as Akkermansia muciniphila and Bacteroides acidifaciens, and decreased that of conditional pathogenic bacteria such as Klebsiella michiganensis and K. oxytoca. LRP also elevated fecal SCFA concentrations (acetate, propionate, and butyrate) and suppressed the hepatic Toll-like receptor 4/NOD-like receptor pyrin domain-containing 3/nuclear factor-κB (TLR4/NLRP3/NF-κB) signaling pathway by downregulating the expression of TLR4, MyD88, NLRP3, caspase-1, and interleukin-1β (IL-1β) and thereby reducing NF-κB phosphorylation. In conclusion, LRP exerts potent protective effects against T2DM-associated MASLD by restoring gut microbiota homeostasis, enhancing SCFA production, and inhibiting the hepatic inflammatory signaling pathway. This finding provides a scientific rationale for developing L. ruthenicum-based functional food products.

CLC number: TS201.4 Document code: A Article ID: 1002-6630(2026)08-0225-15

References

【1】
【1】
 
 
Food Science
Pages 225-239

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHAO Y, QIAO M, HU J, et al. Mechanistic Study of Lycium ruthenicum Polysaccharides in Ameliorating Diabetes Complicated by Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice Based on the Gut-Liver Axis. Food Science, 2026, 47(8): 225-239. https://doi.org/10.7506/spkx1002-6630-20250918-142

118

Views

1

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 18 September 2025
Published: 25 April 2026
© Beijing Academy of Food Sciences 2026.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).